Snapshot from Sep 17, 2026 at 07:00 UTC. For live data and tracking: View Live
Tech product showcase

SIBIONICS Showcases GS3 at Melbourne Congress

Analysis based on 7 articles · First reported Jul 20, 2026 · Last updated Aug 31, 2026

Sentiment
20
Attention
1
Articles
7
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The showcase may increase Sibionics' visibility and credibility in the diabetes technology market, potentially boosting adoption of its GS3 sensor. This could intensify competition in the CGM market, affecting established players like Dexcom and Abbott, though the immediate market impact is likely limited as this is a product demonstration at a medical congress.

Medical Devices Diabetes Care Health Technology

Sibionics showcased its GS3 continuous glucose monitoring (CGM) sensor and AI-powered glucose monitoring at the joint IDF-WPR, ADC and Metabolic Diseases 2026 congress held in Melbourne from 18-21 August. The company presented its technology at Booth #1, hosted a scientific symposium titled 'Beyond Glucose: The Integrated Future of CGM, CKM, and AI in Diabetes' jointly with Air Liquide Healthcare, and conducted on-site interviews with Credentialled Diabetes Educators (CDEs). The GS3 sensor is factory-calibrated, lasts 14 days, and has a 2.9 mm profile. Sibionics highlighted its background in brain-computer interfaces, including a retinal prosthesis, as the engineering foundation for its CGM technology. The symposium featured presentations by Professor Sofianos Andrikopoulos (Group CEO of the Australian Diabetes Society), Professor David O Neal (University of Melbourne), Associate Professor Shannon Lin (University of Technology Sydney), and Professor Li Qiang (First Affiliated Hospital of Xi an Jiaotong University). CDEs provided positive feedback on the sensor's comfort and ease of use, and noted potential in AI-supported spike detection and meal logging. Sibionics plans to integrate its sensing platform with continuous ketone monitoring, insulin delivery, and AI to create a comprehensive diabetes management ecosystem.

70 Sibionics hosted symposium Air Liquide
60 Sibionics showcased
priv
Sibionics is the central entity, showcasing its GS3 CGM sensor and AI-powered glucose monitoring at the congress. The event highlights its technological capabilities and future integration plans, potentially enhancing its market position.
Importance 100.0 Sentiment 70.0
stock
Air Liquide Healthcare co-hosted the symposium with Sibionics, reinforcing its involvement in diabetes care and partnership with Sibionics.
Importance 40.0 Sentiment 50.0
ngo
The society's CEO chaired the symposium, lending credibility to the event and highlighting the society's engagement with new diabetes technologies.
Importance 30.0 Sentiment 40.0
per
As session chair and CEO of the Australian Diabetes Society, he lent authority to the symposium.
Importance 20.0 Sentiment 30.0
ngo
The centre's deputy director presented at the symposium, supporting the integration of CGM and ketone monitoring.
Importance 15.0 Sentiment 30.0
oth
A professor from the hospital outlined an AI-driven ecosystem for diabetes management, highlighting international collaboration.
Importance 15.0 Sentiment 30.0
per
Presented clinical evidence on continuous glucose and ketone monitoring, supporting the technology's efficacy.
Importance 15.0 Sentiment 30.0
per
Discussed the potential of CGM for personalised, predictive diabetes support.
Importance 15.0 Sentiment 30.0
per
Outlined an integrated AI-driven ecosystem, reinforcing the future direction of diabetes care.
Importance 15.0 Sentiment 30.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.